Background {#Sec1}
==========

Cognitive impairment is a neurological disorder that occurs in adults, which involves cognitive disorders with impairment in instrumental activities of daily living \[[@CR1], [@CR2]\]. Previous studies have shown that about 234 million patients worldwide undergo surgery each year, and about 41% of elderly patients have cognitive impairment after surgery or anesthesia. Thirteen percent of patients still have cognitive impairment 3 months after discharge \[[@CR3], [@CR4]\]. Cognitive impairment severely affects the prognosis of patients who have undergone general anesthesia surgeries, especially elderly patients, including decreased quality of life, loss of independence, and increased mortality \[[@CR5]\]. Patients with lung cancer frequently encounter postoperative cognitive dysfunction. In elderly patients, severe cognitive impairment is more likely to occur after anesthesia. This may be due to a combination of multiple factors, such as inflammation caused by surgical trauma, infection, opioids, stress, and sleep disorders \[[@CR6]\]. Because the incidence of cognitive impairment is positively correlated with the duration of anesthesia, general anesthetic drugs are thought to be one of the causes of cognitive impairment in elderly patients \[[@CR7]\].

Worldwide, lung cancer occurred in approximately 1.8 million patients in 2012 and caused an estimated 1.6 million deaths \[[@CR8]\]. This is increased from 1.6 million new diagnoses and 1.4 million lung cancer deaths in 2008 \[[@CR9]\]. The treatment for early-stage lung cancer is mainly surgical treatment. Propofol and sevoflurane are the most commonly used general anesthetic drugs in clinical practice \[[@CR10]\]. However, in terms of causing postoperative cognitive functions, there are still controversies regarding the use of propofol anesthesia or sevoflurane anesthesia in elderly patients with lung cancer. Current published studies on this topic were with relatively smaller sample sizes and were lack of consistency. Therefore, we conducted this systematic review and meta-analysis to derive a pooled estimate of the effects of propofol and sevoflurane on postoperative cognitive functions in patients with lung cancer, with an improved statistical power as compared to individual studies. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoints are serum S100beta concentration 24 h after surgery. S100β is glial-specific and is expressed primarily by astrocytes. It functions in the process of neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis, axonal proliferation, and inhibition of microtubule assembly. In the developing central nervous system (CNS), it acts as a neurotrophic factor and neuronal survival protein. In the adult organism, it is usually elevated due to nervous system damage, which makes it a potential clinical marker. S100β is involved in the regulation of cell shape, cell growth, energy metabolism, cell-to-cell communication, contraction, and intracellular signal transduction. The correlation between serum S100β protein levels and cognitive dysfunction.

Methods {#Sec2}
=======

Research protocol overview {#Sec3}
--------------------------

Public-available online databases were searched to identify eligible randomized placebo-controlled trials or prospective cohort studies concerning the effects of propofol and sevoflurane on postoperative cognitive function. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is the serum S100beta concentration 24 h after surgery. Standard mean differences (SMDs) along with 95% confidence intervals (CIs) were extracted and analyzed using random or fixed-effects models. Analyses regarding heterogeneity, risk of bias assessment, and sensitivity were performed.

Search strategies {#Sec4}
-----------------

We searched the databases of Embase, Pubmed, The Cochrane Library, Web of Science, and China National Knowledge Infrastructure (CNKI). Retrieval time is from the database construction time to March 2018. The English search words include propofol, sevoflurane, cognitive, and lung cancer. The Chinese search words are the Chinese translation of the above words. There are no language and time limits. For the retrieved documents, we further tracked their references to include the ones that met the inclusion criteria.

Inclusion and exclusion criteria {#Sec5}
--------------------------------

This study analyzed studies with a population of \> 60 years-old, ASA class I to III patients who had scheduled for lung cancer surgeries, and received propofol or sevoflurane during anesthesia. The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is serum S100beta concentration 24 h after surgery. Specific inclusion criteria and exclusion criteria were reported in Table [1](#Tab1){ref-type="table"}. Table 1Inclusion criteria for study selection in this meta-analysisNumberInclusion criteria1Original prospective cohort studies or randomized controlled trials (RCTs) published in full text and those for which we had full access to all original data and protocols.2The studies evaluated the differences of the effect of propofol and sevoflurane on postoperative cognitive functions.3Regarding the intervening measures between different groups, the only difference is that the two groups received propofol or sevoflurane, respectively. Other conditions should be the same.4Human studies.5Predefined outcomes: incidence of postoperative MMSE scores and the plasma protein S100β at various time points.6No minimal sample size or dosing regimen was required for inclusion.NumberExclusion criteria1The study did not have a control group of patients without propofol use or sevoflurane use.2They were case studies or case series.3The report focused exclusively on other topics or outcomes.4No human data were included.5Except for the difference of anaesthetic administration, there were other differences between the experimental groups and the control groups.6Reviews and duplicated publications.

Data extraction and quality evaluation {#Sec6}
--------------------------------------

Two researchers independently conducted literature screening and quality evaluation of the obtained documents. In case of disagreement, they would reach an agreement by discussion or invite a third party to adjudicate. Data extraction: 1) necessary information included in the study, such as first author and publication date; 2) general data of patients in the experimental group and control group, such as the sex, age, America Society of Anesthesiologist (ASA) classification, intervention measures, operations, etc.; 3) anesthesia methods, including methods of inducing anesthesia and maintenance of anesthesia, and the drug doses; 4) outcomes, including preoperative and postoperative MMSE scores, changes in serum S100beta concentration before and after surgery. The main characteristics of the included studies were summarized in Table [2](#Tab2){ref-type="table"}. Table 2Characteristics of studies included in the meta-analysisAuthorYearCountrySex (M/F)AgeSurgeryASA gradeOutcomesPropofol groupSevoflurane groupMethodNo.MethodNo.Yu et al.2012China44 /3668.8 ± 3.8Lung cancer operationI\~II①②③④⑤⑥Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: propofol40Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: sevoflurane40Tang et al.2014China38 /3270.0 ± 11.7Lung cancer operationI\~II①②③④⑤⑥Induction: etomidate, midazolam, fentanyl, rocuronium;Maintain: propofol35Induction: etomidate, midazolam, fentanyl, rocuronium;Maintain: sevoflurane35Sun et al.2014China77 /2972.2 ± 2.6Lung cancer operationN①②③④⑤⑥Induction: fentanyl and vecuronium bromide;Maintain: propofol 2\~4 mg/kg/min53Induction: fentanyl and vecuronium bromide;Maintain: sevoflurane53Cui et al.2015China94 /7669 ± 12.9Lung cancer operationN①③⑤⑥Induction: fentanyl, etomidate, vecuronium bromide;Maintain: propofol 2\~4 mg/kg/min80Induction: fentanyl, etomidate, vecuronium bromide;Maintain: sevoflurane 1%\~ 3%80Zhang et al.2016China101 /9160.0 ± 6.4Lung cancer operationN①③④⑥Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: propofol96Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: sevoflurane96Wang H et al.2015China41 /3173.5 ± 2.8Lung cancer operationI\~II①②③④⑤⑥Induction: unified rapid induction;Maintain: propofol36Induction: unified rapid induction;Maintain: sevoflurane36Wang F et al.2017China32 /1872.5 ± 3.0Lung cancer operationN①②③④⑤⑥Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: propofol50Induction: midazolam, fentanyl, rocuronium, etomidate;Maintain: sevoflurane50Zhao et al.2014China80 /3073.5 ± 2.0Lung cancer operationI\~II①②③④⑤⑥Induction: fentanyl and vecuronium bromide;Maintain: propofol 2\~4 mg/kg/min50Induction: fentanyl and vecuronium bromide;Maintain: sevoflurane60Chen et al.2015China43 /3569.2 ± 3.2Lung cancer operationN①②③④⑤⑥Induction: midazolam, propofol, fentanyl and vecuronium bromide;Maintain: propofol 6\~10 mg/kg/min39Induction: midazolam, propofol, fentanyl and vecuronium bromide;Maintain: sevoflurane39Huang et al.2015China50 /4068.2 ± 1.3Lung cancer operationN①②③④⑤⑥Induction: rocuronium, fentanyl, midazolam, etomidate;Maintain: propofol45Induction: rocuronium, fentanyl, midazolam, etomidate;Maintain: sevoflurane45Lin et al.2017China54/4068.23 ± 1.32Lung cancer operationI\~II①②③④⑥Induction: propofol, midazolam, vecuronium, fentanyl;Maintain: propofol40Induction: propofol, midazolam, vecuronium, fentanyl;Maintain: sevoflurane54Zhang et al.2017China41/29P: 74.8 ± 2.1; S: 74.3 ± 2.5Lung cancer operationI\~II②③④Induction: fentanyl, etomidate, midazolam, rocuronium;Maintain: propofol35Induction: fentanyl, etomidate, midazolam, rocuronium;Maintain: sevoflurane35Yang et al.2017China84/3671.9 ± 2.5Lung cancer operationN①②③④⑤⑥Induction: unified rapid induction;Maintain: propofol60Induction: unified rapid induction;Maintain: sevoflurane60Tian et al.2017China38/24P: 68.3 ± 13.5; S: 65.5 ± 16.2Lung cancer operationI\~II①③⑥Induction: midazolam, fentanyl, propofol;Maintain: propofol31Induction: midazolam, fentanyl, sevoflurane;Maintain: propofol31*N* Not mentioned, *ASA* American society of anesthesiology, ① = Preoperative MMSE score, ② = MMSE score at 6 h after surgery, ③ = MMSE score at 1 day after surgery, ④ = MMSE score at 3 day after surgery, ⑤ = MMSE score at 7 day after surgery, ⑥ = Plasma S100β protein level at 1 day after surgery, *P* Propofol, *S* Sevoflurane

Quality Evaluation: The Cochrane System Evaluation Criteria was used for this evaluation. We used the Cochrane Risk Bias Assessment Tool to analyze the literature bias \[[@CR11]\].

Patient involvement {#Sec7}
-------------------

There was no patient involvement in the design and implementation of this study.

Statistical analysis {#Sec8}
--------------------

The primary endpoints are postoperative mini-mental state examination (MMSE) scores at various time points; the secondary endpoint is serum S100beta concentration 24 h after surgery. STATA 13.0 (StataCorp LP, College Station, TX, USA) software was used for statistical analysis. In order to eliminate the influence of different units and differences in the means among different research studies, we analyzed the standard mean difference (SMD) and its 95% CI. We used the Galbr plot, I^2^ test and Cochran's Q-test to determine whether the results are heterogeneous, and at the same time, we analyzed the heterogeneity by calculating I^2^. If the *P* value\> 0.1 and I2 \< 50%, the heterogeneity between the results is not apparent, so that a fixed effect model would be used for this meta-analysis; when *P* ≤ 0.1 and I2 ≥ 50%, it indicates that the results of the studies are heterogeneous. If the heterogeneity is apparent, then it could be eliminated by searching for the source of heterogeneity and analyzing the sensitivity; if the source of heterogeneity is not bright, the meta-analysis would be performed using a random-effect model. A bias risk assessment tool was used to assess the risk of bias. Detailed explanations of the mentioned analyses were included in Table [3](#Tab3){ref-type="table"}. Two-tailed *P* values less than 0.05 were considered as statistically significant. Table 3The statistical methods used in this meta-analysis and their explanationGoals and UsagesStatistic MethodsExplanations and InstructionsTo evaluate heterogeneity between the included studiesGalbr plotIn Galbr figure, if the points all fall within the area between the upper line and the lower line, it can be taken as an evidence of homogeneity; otherwise, there is heterogeneity.Cochran's Q testCochran's Q test is an extension to the McNemar test for related samples that provides a method for testing for differences between three or more matched sets of frequencies or proportions. Heterogeneity was also considered significant if *P* \< 0.05 using the Cochran's Q test.I^2^ index testThe I^2^ index measures the extent of true heterogeneity dividing the difference between the result of the Q test and its degrees of freedom (k -- 1) by the Q value itself, and multiplied by 100. I^2^ values of 25, 50 and 75% were used as evidence of low, moderate and high heterogeneity, respectively.To examine the stability of the pooled resultsSensitivity analysisA sensitivity analysis was performed using the one-at-a-time method, which involved omitting one study at a time and repeating the meta-analysis. If the omission of one study significantly changed the result, it implied that the result was sensitive to the studies included.Publication bias testContour-enhanced funnel plotVisual inspection of the Contour-enhanced funnel plots was used to assess potential publication bias. Asymmetry in the plots, which may be due to studies missing on the left-hand side of the plot that represents low statistical significance, suggested publication bias. If studies were missing in the high statistical significance areas (on the right-hand side of the plot), the funnel asymmetry was not considered to be due to publication bias

Results {#Sec9}
=======

Search results {#Sec10}
--------------

The flowchart summarizing the study selection process following the PRISMA statement was reported in Fig. [1](#Fig1){ref-type="fig"}. A total of 1626 studies were identified in the initial search, including 108 studies from PubMed, 1131 studies from EMBASE, 148 studies from Cochrane Library, 195 studies from Web of Science, 44 studies from CNKI, and one academic meeting abstracts (Table [4](#Tab4){ref-type="table"}). After screening based on inclusion and exclusion criteria, 372 articles were retrieved as eligible and then reviewed by two independent reviewers. Finally, fourteen studies, including 1404 patients, were included in the final meta-analysis \[[@CR12]--[@CR25]\]. Fig. 1Literature search and selection of articles Table 4Searching strategies and results for different databases (cut-off date: April 20, 2017)DatabaseDatabase URLSearch strategyResultsPubmed<https://www.ncbi.nlm.nih.gov/pubmed/>("sevoflurane" \[Supplementary Concept\] OR "sevoflurane" \[All Fields\]) AND ("propofol" \[MeSH Terms\] OR "propofol" \[All Fields\]) AND ("lung" \[MeSH Terms\] OR "lung" \[All Fields\])108Embase<https://www.embase.com/>('sevoflurane'/exp. OR sevoflurane) AND ('propofol'/exp. OR propofol) AND ('lung'/exp. OR lung)1131Cochrane Library<http://www.cochranelibrary.com/>Sevoflurane AND Propofol AND lung:ti, ab, kw148Web of Science<http://apps.webofknowledge.com/>TOPIC: (Sevoflurane AND Propofol AND postoperative AND pain); Timespan: All years.Indexes: SCI-EXPANDED, SSCI, A&HCI, ESCI.195CNKI<http://www.cnki.net/>Search conditions: (topic = sevoflurane propofol lung cancer) (fuzzy matching), album navigation: all; database: literature cross-database search; search method: cross-database searchDatabase: Literature44Searching results and information of relevant academic meeting abstractsYearCityMeeting nameArticle titleWhether included2015Beijing, P.R. ChinaChinese seminar on translational medicine and integrative medicineDifference of postoperative cognitive functions under propofol or sevoflurane anesthesia for lung cancer surgeryNo

Patient characteristics {#Sec11}
-----------------------

In terms of patient race group, all studies were performed in patients of Asian backgrounds. There was one study published in English and 13 studies in Chinese. The characteristics of the studies included in this meta-analysis were listed in Table [2](#Tab2){ref-type="table"} in detail.

Meta-analysis results and bias assessment results {#Sec12}
-------------------------------------------------

The main results, including heterogeneity tests, effect models adopted accordingly, and the pooled SMDs with their 95% CI and the *P* value of this meta-analysis were presented in Table [5](#Tab5){ref-type="table"}. The Galbr plots for the association between the use of narcotic drugs and postoperative cognitive function were shown in Fig. [2](#Fig2){ref-type="fig"}, suggesting that there was no heterogeneity only among the 10 studies \[[@CR12], [@CR13], [@CR15], [@CR17], [@CR19]--[@CR22], [@CR24], [@CR25]\] with continuous data focusing on MMSE scores 7 days after the surgery, but not among other comparisons. Using fixed-effects model, the pooled SMD for the 10 studies was − 0.422 (95% CI: − 0.549, − 0.295, Z = 6.52; *P* \< 0.001), the pooled WMD was − 0.371 (95% CI: − 0.493, − 0.249, P \< 0.001), indicating that in terms of MMSE scores 7 days postoperatively, propofol has a greater adverse effect on cognitive function in the elderly patients with lung cancer than sevoflurane. The pooled SMD or WMD in issues of preoperative MMSE scores suggested no statistical difference (SMD -0.038, 95% CI: − 0.274, 0.198; WMD − 0.040, 95% CI: − 0.288, 0.208; Z = 0.31; *P* = 0.753). Then the pooled SMD in issues of postoperative MMSE scores at different time points were calculated using the random-effects model (except the MMSE score-7d). There were significant differences in issues of MMSE 6 h (11 studies; SMD -1.391, 95% CI -2.024, − 0.757; WMD -1.922, 95% CI -2.571, − 1.274; *p* \< 0.001), MMSE 24 h (14 studies; SMD -1.106, 95% CI -1.588, − 0.624; WMD -1.504, 95% CI -2.253, − 0.755; p \< 0.001), MMSE 3d (11 studies; SMD -1.065, 95% CI -1.564, − 0.566; WMD -1.376, 95% CI -2.044, − 0.708; p \< 0.001), MMSE 7d (10 studies; SMD -0.422, 95% CI -0.549, − 0.295; WMD -0.371, 95% CI -0.493, − 0.249; p \< 0.001), and the serum S100beta concentration at 1 day after surgery (13 studies; SMD 0.746, 95% CI 0.475, 1.017; WMD 0.018, 95% CI 0.016, 0.020; *p* \< 0.001) (Fig. [3](#Fig3){ref-type="fig"}). We assessed the risk of bias using the Cochrane risk of bias tool \[[@CR11]\]. Table [6](#Tab6){ref-type="table"} reported detailed results from the risk of a bias assessment tool. Table 5The results of the meta-analysis for the effect of propofol and sevoflurane on postoperative cognitive functionComparative itemsData typeHeterogeneity testTest of AssociationPublication biasMMSE and protein markerItemsQ valued.f.I-squaredTau-squared*P* ValueHeterogeneityEffect modelPooled WMDWMD 95% CIPooled SMDSMD\
95% CIZ value*P* valueStatistical significancePreoperative cognitive functionPreoperative MMSEContinuous55.091278.2%0.14490.000YesRandom-0.040\[−0.288, 0.208\]− 0.038\[− 0.274, 0.198\]0.310.753NoNoPostoperative cognitive function evaluationMMSE 6 hContinuous199.171095.0%1.08260.000YesRandom−1.922\[−2.571, − 1.274\]−1.391\[− 2.024, −0.757\]4.300.000YesNoMMSE 24 hContinuous216.541394.0%0.78590.000YesRandom−1.504\[−2.253, −0.755\]− 1.106\[− 1.588, − 0.624\]4.500.000YesNoMMSE 3dContinuous140.361092.9%0.65850.000YesRandom−1.376\[−2.044, −0.708\]− 1.065\[− 1.564, − 0.566\]4.190.000YesNoMMSE 7dContinuous16.75946.3%NA0.053Nofixed−0.371\[−0.493, − 0.249\]−0.422\[− 0.549, − 0.295\]6.520.000YesNoProtein marker S100βS100β 1dContinuous67.941282.3%0.20240.000YesRandom0.018\[0.016, 0.020\]0.746\[0.475, 1.017\]5.390.000YesNo Fig. 2Galbr plots of the included studies focusing on the effects of propofol and sevoflurane on postoperative cognitive function (**a** preparative MMSE score; **b** MMSE score 6 h after surgery; **c** MMSE score 24 h after surgery; **d** MMSE score 3 days after surgery; **e** MMSE score 7 days after surgery; **f** serum S100beta concentration24 hours after surgery) Fig. 3Forest plots of the included studies focusing on the effects of propofol and sevoflurane on postoperative cognitive function (**a** preparative MMSE score; **b** MMSE score 6 h after surgery; **c** MMSE score 24 h after surgery; **d** MMSE score 3 days after surgery; **e** MMSE score 7 days after surgery; **f** serum S100beta concentration 24 h after surgery) Table 6Study quality: review authors' judgments about each risk of bias item for each included studyAuthorYearRandom sequence generationAllocation concealmentBlinding of participants and personnelBlinding of outcome assessmentIncomplete outcome dataSelective reportingOther sources of biasYu et al.2012Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskTang et al.2014Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskSun et al.2014Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskCui et al.2015Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskZhang et al.2016Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskWang H et al.2015Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskWang F et al.2017Random number tableUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskZhao et al.2014Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskChen et al.2015Unclear riskUnclear riskUnclear riskUnclear riskLow riskLow riskUnclear riskHuang et al.2015Random number tableUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskLin et al.2017Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskZhang et al.2017Unclear riskUnclear riskUnclear riskUnclear riskLow riskUnclear riskUnclear riskYang et al.2017Low riskUnclear riskUnclear riskUnclear riskLow riskLow riskUnclear riskTian et al.2017Low riskUnclear riskUnclear riskUnclear riskLow riskLow riskUnclear risk

Sensitivity analysis {#Sec13}
--------------------

To assess if a single study could affect the final SMDs, each study was removed one time, and the data re-pooled. The analysis results demonstrated that the pooled SMDs were not affected by deleting every single study. Figure [4](#Fig4){ref-type="fig"} showed sensitivity analysis results in issues of postoperative pain and propofol/remifentanil use. Fig. 4Sensitivity analyses of the included studies focusing on the effects of propofol and sevoflurane on postoperative cognitive function (**a** preparative MMSE score; **b** MMSE score 6 h after surgery; **c** MMSE score 24 h after surgery; **d** MMSE score 3 days after surgery; **e** MMSE score 7 days after surgery; **f** serum S100beta concentration 24 h after surgery)

Publication bias {#Sec14}
----------------

The contour-enhanced funnel plots (this term's explanation could be seen in Table [3](#Tab3){ref-type="table"}) were adopted to estimate potential publication biases, showing that most of the studies had missing areas for low statistical significance (the left-hand side of the plot), indicating no publication bias in present studies (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Contour-enhanced funnel plots of the included studies focusing on the effects of propofol and sevoflurane on postoperative cognitive function (**a** preparative MMSE score; **b** MMSE score 6 h after surgery; **c** MMSE score 24 h after surgery; **d** MMSE score 3 days after surgery; **e** MMSE score 7 days after surgery; **f** serum S100beta concentration 24 h after surgery)

Discussion {#Sec15}
==========

The potential risk for cognitive impairment following surgery and anesthesia is a common concern, especially in the elderly and more fragile patients. The risk for various neurocognitive effects is thus an area of importance. The independent impact of surgery and anesthesia is still not known. Likewise, the independent effect of different drugs used during anesthesia is a matter of debate, as is the number and amounts of drugs used and the "depth of anesthesia." So, understanding the drug-related phenomenon and mechanisms for postoperative cognitive impairment is essential. This meta-analysis aims to compare the effects of propofol and sevoflurane anesthesia on postoperative cognitive function in elderly patients with lung cancer. This meta-analysis compared the effects of propofol and sevoflurane anesthesia on postoperative cognitive function in elderly patients (\> 60-year-old) with lung cancer. Results suggested that propofol has a more significant adverse effect on cognitive function in elderly patients with lung cancer than sevoflurane. There were significant differences in issues of MMSE 6 h, MMSE 24 h, MMSE 3d, MMSE 7d, and the serum S100beta concentration at 1 day after surgery (all *p* \< 0.01). Regarding the two drugs analyzed, the half-life of elimination of propofol has been estimated to be between 2 and 24 h. However, its duration of clinical effect is much shorter, because propofol is rapidly distributed into peripheral tissues. When used for IV sedation, a single dose of propofol typically wears off within minutes. The half-life of elimination of sevoflurane is 15--23 h.

At present, there is no uniform standard for the assessment of cognitive dysfunction in the world, and the most commonly used standard clinically is the MMSE score \[[@CR26]\]. Studies found that the sensitivity and specificity of the MMSE method for assessing cognitive brain function were 87 and 82%, respectively \[[@CR27]\]. The MMSE method is feasible and straightforward and is widely used for the screening of clinical cognitive dysfunction and cognitive decline \[[@CR28]\]. The results of this meta-analysis showed that the MMSE scores at 6 h, 1d, 3d, and 7d after intravenous propofol anesthesia were significantly lower than those of sevoflurane. The reason may be that the sevoflurane has a shorter action time and is eliminated quickly. Laboratory data also showed that rats pretreated with high concentrations of sevoflurane could be effectively protected from focal cerebral ischemia, thus reducing neurological deficit scores, the volume of cerebral infarction, and cerebral edema areas. The incidence of post-cognitive disorders is adversely associated with higher concentrations of sevoflurane as a potential protective factor in non-cardiovascular procedures \[[@CR29]\]. Experimental data have demonstrated that it may be because of the up-regulation of the expression levels of NR1 and NR2 subunits of hippocampal N-methyl-D-aspartate receptors that sevoflurane has a slighter effect on cognitive function in the elderly patients than propofol \[[@CR30]\].

On a contour-enhanced funnel plot, contours of statistical significance are overlaid on the funnel plot. Adding contours of statistical significance facilitates the assessment of whether the areas where studies exist are areas of statistical significance and whether the areas where studies are potentially missing correspond to areas of low statistical significance. Generally, if studies appear to be missing in areas of low statistical significance, then it is possible that the asymmetry is due to publication bias. Conversely, studies perceived to be missing areas of high statistical significance likely do not suffer from publication bias as a source of funnel asymmetry. In the present meta-analysis, the funnel plot indicated no publication bias.

This meta-analysis has a few limitations. Firstly, we included only 14 articles. Although all these studies were conducted with propofol anesthesia and sevoflurane anesthesia as the experimental group and the control group, respectively, the doses of the drugs used for the elderly patients with lung cancer, the length of the operation time, and the use of adjuvant drugs were not the same. So, the problem of generalizability might exist. Secondly, most literature tends to report positive outcomes, while the studies with negative results are often not reported. Though not suggested via contour-enhanced funnel plots, the possibility of potential publication bias in included studies should not be overlooked. Thirdly, we did not perform a grey literature search, which might cause overestimations of effect sizes. Grey literature stands for manifold document types produced on all levels of government, academics, business and industry in print and electronic formats that are protected by intellectual property rights, of sufficient quality to be collected and preserved by libraries and institutional repositories, but not controlled by commercial publishers; i.e. where publishing is not the primary activity of the producing body. Fourthly, there are several tools more extensive tools available for assessment of recovery; however, in the present study, we only adopted MMSE as the outcome because of the data availability (MMSE is the most commonly used for screening). Although one may argue that merely presenting repeated MMSE scores is not sufficient for assessment of cognitive capacity and discriminating differences between groups, we believe that at this present time, due to the data availability mentioned above, the MMSE could say something. Fifthly, most of the included studies did not report enough the details of each patient, so it is not easy to separate between emergence reaction within hours from emergence, early cognitive changes - delirium and more protracted changes. Additionally, the many included studies had a relatively low methodology quality, so more rigorous large-scale randomized controlled trials are needed. Sixthly, the vast majority of the studies were conducted in China. The inter-racial variability of propofol anesthesia is well described. Therefore, it is not sure if the results are valid for other races. Seventhly, as is understood, co-administered drugs differed in included studies, but did any of the studies include regional anesthetic techniques? Could the greater peri-operative hypotension sometimes see with propofol have been a cause? Due to lacking these related data, the accuracy of the study's conclusions will be questioned.

Conclusions {#Sec16}
===========

In summary, propofol has a more significant adverse effect on postoperative cognitive function in lung cancer patients than sevoflurane. In the included studies, some of the documents are of low quality and may affect the stability and reliability of the final results. Therefore, larger samples, more rigorous design, and higher quality tests are still needed for verification.

ASA

:   America Society of Anesthesiologist

CI

:   Confidence interval

CNKI

:   China National Knowledge Infrastructure

CNS

:   Central nervous system

MMSE

:   Mini-mental state examination

SMD

:   Standard mean difference
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